BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. EPSTEIN-BARR VIRUS (EBV) INFECTION IN INFECTIOUS MONONUCLEOSIS: VIRUS LATENCY, REPLICATION AND PHENOTYPE OF EBV-INFECTED CELLS. J Pathol 1997;182:151-9. [DOI: 10.1002/(sici)1096-9896(199706)182:2<151::aid-path824>3.0.co;2-3] [Cited by in Crossref: 129] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Bandobashi K, Liu A, Nagy N, Kis LL, Nishikawa J, Björkholm M, Klein G, Klein E. EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells. Virus Genes 2005;30:323-30. [PMID: 15830149 DOI: 10.1007/s11262-004-6774-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, Jankowska-Gan E, Burlingham WJ, Sun X, Gulley ML. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol. 2011;85:165-177. [PMID: 20980506 DOI: 10.1128/jvi.01512-10] [Cited by in Crossref: 192] [Cited by in F6Publishing: 134] [Article Influence: 16.0] [Reference Citation Analysis]
3 Taylor GM, Raghuwanshi SK, Rowe DT, Wadowsky RM, Rosendorff A. Endoplasmic reticulum stress causes EBV lytic replication. Blood 2011;118:5528-39. [PMID: 21849482 DOI: 10.1182/blood-2011-04-347112] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
4 Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 2008;111:1420-7. [PMID: 17991806 DOI: 10.1182/blood-2007-06-093278] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
5 Kutok JL, Klumpp S, Simon M, MacKey JJ, Nguyen V, Middeldorp JM, Aster JC, Wang F. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques. J Virol 2004;78:3455-61. [PMID: 15016868 DOI: 10.1128/jvi.78.7.3455-3461.2004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ciccocioppo R, Racca F, Scudeller L, Piralla A, Formagnana P, Pozzi L, Betti E, Vanoli A, Riboni R, Kruzliak P, Baldanti F, Corazza GR. Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease. Immunol Res 2016;64:191-203. [PMID: 26659090 DOI: 10.1007/s12026-015-8737-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
7 Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 2002;195:893-905. [PMID: 11927633 DOI: 10.1084/jem.20011692] [Cited by in Crossref: 200] [Cited by in F6Publishing: 193] [Article Influence: 10.0] [Reference Citation Analysis]
8 Kapatai G, Murray P. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol 2007;60:1342-9. [PMID: 18042690 DOI: 10.1136/jcp.2007.050146] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
9 Siegler G, Kremmer E, Gonnella R, Niedobitek G. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma. Mol Pathol 2003;56:156-61. [PMID: 12782762 DOI: 10.1136/mp.56.3.156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
10 Calattini S, Sereti I, Scheinberg P, Kimura H, Childs RW, Cohen JI. Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH. Blood 2010;116:4546-59. [PMID: 20699441 DOI: 10.1182/blood-2010-05-285452] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
11 Niedobitek G, Agathanggelou A, Steven N, Young LS. Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells. Mol Pathol. 2000;53:37-42. [PMID: 10884920 DOI: 10.1136/mp.53.1.37] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
12 Minamitani T, Yasui T, Ma Y, Zhou H, Okuzaki D, Tsai CY, Sakakibara S, Gewurz BE, Kieff E, Kikutani H. Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proc Natl Acad Sci U S A 2015;112:11612-7. [PMID: 26305967 DOI: 10.1073/pnas.1514484112] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
13 Lin Z, Swan K, Zhang X, Cao S, Brett Z, Drury S, Strong MJ, Fewell C, Puetter A, Wang X, Ferris M, Sullivan DE, Li L, Flemington EK. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells. J Virol 2016;90:3469-79. [PMID: 26764001 DOI: 10.1128/JVI.02830-15] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
14 Gruffat H, Kadjouf F, Mariamé B, Manet E. The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J Virol 2012;86:6023-32. [PMID: 22457524 DOI: 10.1128/JVI.00159-12] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 5.2] [Reference Citation Analysis]
15 Bornkamm GW, Behrends U, Mautner J. The infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cells. Proc Natl Acad Sci U S A 2006;103:7201-2. [PMID: 16651525 DOI: 10.1073/pnas.0602077103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Wei P, Niu M, Pan S, Zhou Y, Shuai C, Wang J, Peng S, Li G. Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy. Stem Cell Res Ther. 2014;5:44. [PMID: 25158069 DOI: 10.1186/scrt433] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
17 Islas-Ohlmayer M, Padgett-Thomas A, Domiati-Saad R, Melkus MW, Cravens PD, Martin Mdel P, Netto G, Garcia JV. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J Virol 2004;78:13891-900. [PMID: 15564497 DOI: 10.1128/JVI.78.24.13891-13900.2004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
18 Faulkner GC, Burrows SR, Khanna R, Moss DJ, Bird AG, Crawford DH. X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol 1999;73:1555-64. [PMID: 9882361 DOI: 10.1128/JVI.73.2.1555-1564.1999] [Cited by in Crossref: 78] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
19 Endo LH, Sakano E, Camargo LA, Ferreira DR, Pinto GA, Vassallo J. The EBV action in tonsils and adenoids. Int Congr Ser 2003;1257:263-7. [PMID: 32288137 DOI: 10.1016/S0531-5131(03)01161-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, Hammerschmitt N, Khan N, Palendira U, Leese AM, Timms JM. Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest. 2005;115:2546-2555. [PMID: 16110323 DOI: 10.1172/jci24810] [Cited by in Crossref: 76] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
21 Mohamed G, Vrzalikova K, Cader FZ, Vockerodt M, Nagy E, Flodr P, Yap LF, Diepstra A, Kluin PM, Rosati S, Murray P. Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma. J Gen Virol 2014;95:1861-9. [PMID: 24893782 DOI: 10.1099/vir.0.066712-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Walling DM, Ray AJ, Nichols JE, Flaitz CM, Nichols CM. Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation. J Virol 2007;81:7249-68. [PMID: 17376908 DOI: 10.1128/JVI.02754-06] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
23 El-Sharkawy A, Al Zaidan L, Malki A. Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis. Front Oncol 2018;8:265. [PMID: 30116721 DOI: 10.3389/fonc.2018.00265] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
24 Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells. Immunology 2006;117:379-85. [PMID: 16476057 DOI: 10.1111/j.1365-2567.2005.02311.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
25 Vezina HE, Balfour HH Jr, Weller DR, Anderson BJ, Brundage RC. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis. J Clin Pharmacol 2010;50:734-42. [PMID: 19897764 DOI: 10.1177/0091270009351884] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
26 Khleif SN, Frederickson H. The role of vaccines in cancer prevention. Cancer Treat Res 2001;106:283-306. [PMID: 11225007 DOI: 10.1007/978-1-4615-1657-6_12] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
27 Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol. 2001;82:149-170. [PMID: 11488990 DOI: 10.1046/j.1365-2613.2001.00190.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Rowe M, Fitzsimmons L, Bell AI. Epstein-Barr virus and Burkitt lymphoma. Chin J Cancer. 2014;33:609-619. [PMID: 25418195 DOI: 10.5732/cjc.014.10190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
29 Incrocci R, McCormack M, Swanson-Mungerson M. Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas. J Gen Virol 2013;94:1127-33. [PMID: 23303827 DOI: 10.1099/vir.0.049221-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
30 Adamson AL, Wright N, LaJeunesse DR. Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein. Genetics 2005;171:1125-35. [PMID: 16079238 DOI: 10.1534/genetics.105.042572] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
31 Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 2001;82:149-70. [PMID: 11488990 DOI: 10.1046/j.1365-2613.2001.iep0082-0149-x] [Cited by in F6Publishing: 61] [Reference Citation Analysis]
32 Klein E, Nagy N, Rasul AE. EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency. Oncoimmunology 2013;2:e23035. [PMID: 23526738 DOI: 10.4161/onci.23035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
33 Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 2006;103:7065-70. [PMID: 16606841 DOI: 10.1073/pnas.0510512103] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 8.4] [Reference Citation Analysis]
34 Kurth J, Hansmann ML, Rajewsky K, Küppers R. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci U S A 2003;100:4730-5. [PMID: 12665622 DOI: 10.1073/pnas.2627966100] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 5.1] [Reference Citation Analysis]
35 Mishra R, Kumar A, Ingle H, Kumar H. The Interplay Between Viral-Derived miRNAs and Host Immunity During Infection. Front Immunol 2019;10:3079. [PMID: 32038626 DOI: 10.3389/fimmu.2019.03079] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
36 Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM; NeuroproMiSe EBV Working Group. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134:2772-86. [PMID: 21846731 DOI: 10.1093/brain/awr197] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 11.0] [Reference Citation Analysis]
37 Kang MS, Kieff E. Epstein-Barr virus latent genes. Exp Mol Med 2015;47:e131. [PMID: 25613728 DOI: 10.1038/emm.2014.84] [Cited by in Crossref: 145] [Cited by in F6Publishing: 137] [Article Influence: 20.7] [Reference Citation Analysis]
38 Verbeke CS, Wenthe U, Bergler WF, Zentgraf H. Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status. Clin Exp Immunol 2000;120:294-300. [PMID: 10792379 DOI: 10.1046/j.1365-2249.2000.01181.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
39 Vrzalikova K, Vockerodt M, Leonard S, Bell A, Wei W, Schrader A, Wright KL, Kube D, Rowe M, Woodman CB, Murray PG. Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas. Blood 2011;117:5907-17. [PMID: 21411757 DOI: 10.1182/blood-2010-09-307710] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 6.3] [Reference Citation Analysis]
40 Pegtel DM, Middeldorp J, Thorley-Lawson DA. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 2004;78:12613-24. [PMID: 15507648 DOI: 10.1128/JVI.78.22.12613-12624.2004] [Cited by in Crossref: 82] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
41 Zhao L, Xie F, Wang TT, Liu MY, Li JL, Shang L, Deng ZX, Zhao PX, Ma XM. Chlorpyrifos Induces the Expression of the Epstein-Barr Virus Lytic Cycle Activator BZLF-1 via Reactive Oxygen Species. Oxid Med Cell Longev 2015;2015:309125. [PMID: 26257840 DOI: 10.1155/2015/309125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
42 Barros MHM, Vera-Lozada G, Segges P, Hassan R, Niedobitek G. Revisiting the Tissue Microenvironment of Infectious Mononucleosis: Identification of EBV Infection in T Cells and Deep Characterization of Immune Profiles. Front Immunol 2019;10:146. [PMID: 30842768 DOI: 10.3389/fimmu.2019.00146] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
43 Fingeroth JD, Diamond ME, Sage DR, Hayman J, Yates JL. CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J Virol 1999;73:2115-25. [PMID: 9971794 DOI: 10.1128/JVI.73.3.2115-2125.1999] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
44 Huang SY, Fang CY, Wu CC, Tsai CH, Lin SF, Chen JY. Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine. PLoS One 2013;8:e84919. [PMID: 24376853 DOI: 10.1371/journal.pone.0084919] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
45 Gruffat H, Lupo J, Morand P, Boyer V, Manet E. The nuclear and adherent junction complex component protein ubinuclein negatively regulates the productive cycle of Epstein-Barr virus in epithelial cells. J Virol 2011;85:784-94. [PMID: 21084479 DOI: 10.1128/JVI.01397-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
46 Tornóczky T, Kelényi G, Pajor L. EBER oligonucleotide RNA in situ hybridization in EBV associated neoplasms. Pathol Oncol Res 1998;4:201-5. [PMID: 9761938 DOI: 10.1007/BF02905249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Bornkamm GW, Hammerschmidt W. Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001;356:437-59. [PMID: 11313004 DOI: 10.1098/rstb.2000.0781] [Cited by in Crossref: 101] [Cited by in F6Publishing: 95] [Article Influence: 4.8] [Reference Citation Analysis]
48 Polepole P, Bartenslager A, Liu Y, Petro TM, Fernando S, Zhang L. Epstein-Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice. J Med Virol 2021;93:3813-23. [PMID: 32543727 DOI: 10.1002/jmv.26188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Incrocci R, Hussain S, Stone A, Bieging K, Alt LA, Fay MJ, Swanson-Mungerson M. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation. Cell Immunol 2015;297:108-19. [PMID: 26255694 DOI: 10.1016/j.cellimm.2015.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
50 Brink AA, Meijer CJ, Nicholls JM, Middeldorp JM, van den Brule AJ. Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders. Mol Pathol 2001;54:98-102. [PMID: 11322171 DOI: 10.1136/mp.54.2.98] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
51 Lam JKP, Hui KF, Ning RJ, Xu XQ, Chan KH, Chiang AKS. Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection. Front Microbiol 2018;9:416. [PMID: 29599759 DOI: 10.3389/fmicb.2018.00416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
52 Mueller NE, Lennette ET, Dupnik K, Birmann BM. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis. Int J Cancer 2012;130:2886-91. [PMID: 21805472 DOI: 10.1002/ijc.26334] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
53 Ehlin-Henriksson B, Liang W, Cagigi A, Mowafi F, Klein G, Nilsson A. Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection. Immunology 2009;127:549-57. [PMID: 19604305 DOI: 10.1111/j.1365-2567.2008.03029.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
54 Gotoh K, Ito Y, Maruo S, Takada K, Mizuno T, Teranishi M, Nakata S, Nakashima T, Iwata S, Goshima F, Nakamura S, Kimura H. Replication of Epstein-Barr virus primary infection in human tonsil tissue explants. PLoS One 2011;6:e25490. [PMID: 21998663 DOI: 10.1371/journal.pone.0025490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Yau TO, Tang CM, Yu J. Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments. World J Gastroenterol 2014; 20(21): 6448-6456 [PMID: 24914366 DOI: 10.3748/wjg.v20.i21.6448] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
56 Kwok H, Chan KW, Chan KH, Chiang AK. Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects. PLoS One 2015;10:e0120710. [PMID: 25807555 DOI: 10.1371/journal.pone.0120710] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
57 Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 2009;83:7749-60. [PMID: 19439479 DOI: 10.1128/JVI.00108-09] [Cited by in Crossref: 82] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
58 Gargouri B, Van Pelt J, El Feki Ael F, Attia H, Lassoued S. Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines. Mol Cell Biochem 2009;324:55-63. [PMID: 19082543 DOI: 10.1007/s11010-008-9984-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
59 Tan GW, Jiang P, Nolte IM, Kushekhar K, Veenstra RN, Hepkema BG, Jarrett RF, van den Berg A, Diepstra A. HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients. Cancers (Basel) 2021;13:5833. [PMID: 34830986 DOI: 10.3390/cancers13225833] [Reference Citation Analysis]
60 Rowe M, Zuo J. Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity. Microbes Infect 2010;12:173-81. [PMID: 20004735 DOI: 10.1016/j.micinf.2009.12.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
61 Meru N, Davison S, Whitehead L, Jung A, Mutimer D, Rooney N, Kelly D, Niedobitek G. Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens. Mol Pathol 2001;54:264-9. [PMID: 11477143 DOI: 10.1136/mp.54.4.264] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
62 Niedobitek G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 2000;53:248-54. [PMID: 11091848 DOI: 10.1136/mp.53.5.248] [Cited by in Crossref: 126] [Cited by in F6Publishing: 109] [Article Influence: 5.7] [Reference Citation Analysis]
63 Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol. 2001;82:149-170. [PMID: 11488990 DOI: 10.1111/j.1365-2613.2001.iep190.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
64 Jiang R, Gu X, Nathan CO, Hutt-Fletcher L. Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells. J Oral Pathol Med 2008;37:626-33. [PMID: 18710421 DOI: 10.1111/j.1600-0714.2008.00681.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
65 Heath E, Begue-Pastor N, Chaganti S, Croom-Carter D, Shannon-Lowe C, Kube D, Feederle R, Delecluse HJ, Rickinson AB, Bell AI. Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog 2012;8:e1002697. [PMID: 22589726 DOI: 10.1371/journal.ppat.1002697] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
66 Fox CP, Shannon-Lowe C, Rowe M. Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae 2011;2:8. [PMID: 21899744 DOI: 10.1186/2042-4280-2-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
67 Giudice A, D'Arena G, Crispo A, Tecce MF, Nocerino F, Grimaldi M, Rotondo E, D'Ursi AM, Scrima M, Galdiero M. Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis. Oxid Med Cell Longev. 2016;2016:6021934. [PMID: 26977250 DOI: 10.1155/2016/6021934] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
68 Spieker T, Herbst H. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol. 2000;157:51-57. [PMID: 10880375 DOI: 10.1016/s0002-9440(10)64516-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
69 Sun CC, Thorley-Lawson DA. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol 2007;81:13566-77. [PMID: 17898050 DOI: 10.1128/JVI.01055-07] [Cited by in Crossref: 85] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
70 Xu S, Chen H, Zu X, Hao X, Feng R, Zhang S, Chen B, Zeng Z, Chen M, Ye Z, He Y. Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area. Therap Adv Gastroenterol 2020;13:1756284820930124. [PMID: 32913442 DOI: 10.1177/1756284820930124] [Reference Citation Analysis]
71 Vistarop A, Jimenez O, Cohen M, De Matteo E, Preciado MV, Chabay P. Differences in Epstein-Barr Virus Characteristics and Viral-Related Microenvironment Could Be Responsible for Lymphomagenesis in Children. Pathogens 2020;9:E68. [PMID: 31963774 DOI: 10.3390/pathogens9010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]